SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richard davis who wrote (2448)4/18/1997 6:45:00 PM
From: Hank   of 4342
 
Rick,

If everybody remembers a post I wrote a while back, I spoke of the possible problems PRLN could encounter if the FDA doesn't approve of the claims they make in trying to market AndroVir. This appears to be what has happened. I don't think the FDA would object if PRLN marketed AndroVir merely as a dietary supplement with no further claim than "makes you feel better". However, they don't have the clinical data to market as a cure for AIDS. On the plus side, the word is already out anyway, as Paul mentioned. I think this is what he's been alluding to when he said they would market by word of mouth. The AIDS community will already know the real purpose of AndroVir regardless of how it's actually marketed. As Rick M. pointed out, this still doesn't prevent them from selling overseas. In fact, I ran accross a strange usenet post written in Finish awhile back that specifically mentioned "Paracelsian Inc." but since it was written in Finish that was all I could make out. The point is, there are people in Europe who are already aware of PRLN and it's products. Hopefully, the FDA will remove their claws from PRLN without drawing too much blood so they can get on with it. I know I said I'd sell if they missed thier May deadline but at this price, what's the point?

Hank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News